Yubo International Biotech Ltd. (YBGJ)

[Potse]

A couple observations...Q1, S-1......

Q1: First quarter revenue ($462K) and gross margin (68%) were down from the fourth quarter. I would have preferred to see those numbers a little bit higher, but it doesn't overly concern me at the moment. I'm hoping to see some additional growth/acceleration more toward the Q3/Q4 timeframe. I'm not entirely sure if the products were just recently launched/introduced or if the company is just bringing more attention to them (I'm thinking the former) but, YBGJ-related social media accounts in China the last week or two seemed to be focused on two light-application products (skin/hair treatments).

S-1: It is kind of interesting to note how the intense selling pressure that was being exerted on the stock seemed to significantly decrease as soon as the S-1 was filed on May 6. There appears to be much less interest now in selling under that 50-cent price area. It will probably take at least a couple/few months for the S-1 to be declared effective. It will be interesting to see if YBGJ is arranging for institutional involvement in the proposed $2.5 financing and potential insider sales. I think is reasonable to assume will see increased volume in the stock and perhaps increased corporate activity later this year with the financing once the S-1 becomes effective.